4 December 2020
EFPIA Japan

Yoshiaki Aono appointed new Vice Chair of EFPIA JapanTOKYO—4 December 2020— EFPIA Japan announced today that Yoshiaki Aono
(Representative Director, Chairman and President of Nippon Boehringer Ingelheim Co., Ltd.) has
been appointed the new Vice Chair of EFPIA Japan, effective 1 December 2020 with terms until
31 December 2021. This appointment is associated with the resignation of Kazunari Tsunaba.
Together with Takahiko Iwaya (President, Sanofi K.K.) who continues to serve in his position ofVice Chair, Yoshiaki Aono will support Heike Prinz (President and Representative Director, Bayer
Yakuhin, Ltd.), the Chair of EFPIA Japan.
“As the impact of COVID-19 continues to be felt across the world, EFPIA Japan remains
committed to joining forces to fight against the pandemic through innovation and cross-borderindustry-government-academia collaboration. While the global and Japanese healthcare
environments are undergoing rapid change, we will continue to make contributions to debates forfinding solutions that will support sustainability of the healthcare system”, says Yoshiaki Aono.
EFPIA Japan Board Members as of 1 December 2020
Chair

Heike Prinz(Bayer Yakuhin, Ltd.)

Vice Chairs

Takahiko Iwaya(Sanofi K.K.)

Yoshiaki Aono

(Nippon Boehringer Ingelheim Co., Ltd.)Ole Mølskov Bech

(Novo Nordisk Pharma Ltd.)

Stefan Woxström(AstraZeneca K.K.)

Paul Lirette(GlaxoSmithKline K.K.)

Leo Lee(Novartis Pharma K.K.)

Alexandre De Muralt(Merck Biopharma Co., Ltd.)

Kanako Kikuchi(UCB Japan Co., Ltd.)

Yasuhiro Nishimi(Nippon Boehringer Ingelheim Co., Ltd.)Board of Directors

Director General

EFPIA Japan
ThinkPark Tower, 2-1-1, Osaki, Shinagawa-ku, Tokyo 141-6017, Japan
Tel: +81-3- 6417-2032
Fax: +81-3- 6685-4870

NewNew

About EFPIA Japan (http://efpia.jp/)
Established in April 2002, EFPIA Japan represents 21 R&D-based European pharmaceuticalcompanies operating in Japan. In 2019, combined sales from the member companies accounted
for roughly 23% of the pharmaceutical market in Japan. The mission of EFPIA Japan is to“Contribute to healthcare and patients in Japan through the early introduction of innovative
medicines and vaccines”. EFPIA Japan aims to strengthen dialogue with decision-makers in orderto improve Japanese healthcare for all.

About EFPIA (European Federation of Pharmaceutical Industries and Associations)(http://www.efpia.eu)
EFPIA, EFPIA Japan’s partner organisation, is headquartered in Brussels and represents thepharmaceutical industry operating in Europe. Through its direct membership of 36 nationalassociations and 39 leading pharmaceutical companies, EFPIA provides the voice of companies
committed to researching, developing and bringing new medicines to improve health and qualityof life around the world.

Contact:
Yuko Kidoguchi
EFPIA Japan Messaging & Communications Committee
1-6-5 Marunouchi Chiyoda-ku, Tokyo 100-8268
Bayer Holding Ltd.
Tel: 03-6266-7757
Email: yuko.kidoguchi@bayer.com

EFPIA Japan
ThinkPark Tower, 2-1-1, Osaki, Shinagawa-ku, Tokyo 141-6017, Japan
Tel: +81-3- 6417-2032
Fax: +81-3- 6685-4870

Yoshiaki Aono

Current Position
Representative Director, Chairman and President of Nippon Boehringer Ingelheim Co., Ltd.
Representative Director Chairman of Boehringer Ingelheim Seiyaku Co., Ltd
Representative Director Chairman of Boehringer Ingelheim Animal Health Japan Co., Ltd

Born in 1957 in Hyogo Prefecture
Graduated from the Faculty of Engineering at Shizuoka University in March 1979

Professional ExperienceDec 2020

Vice Chair of EFPIA JapanSep 2020

Representative Director, Chairman and President of Nippon Boehringer Ingelheim Co., Ltd.
Representative Director Chairman of Boehringer Ingelheim Seiyaku Co., Ltd
Representative Director Chairman of Boehringer Ingelheim Animal Health Japan Co., Ltd

Jan 2020

Representative Director, President of Human Pharma Business Unit of Nippon Boehringer
Ingelheim Co., Ltd.

Jun 2012

President and Representative Director of Nippon Boehringer Ingelheim Co., Ltd.

May 2012

Joined Nippon Boehringer Ingelheim Co., Ltd. as a DirectorApr 1979

Joined Nihon Ciba-Geigy K.K
Experienced Sales, Marketing and Corporate Planning related functions at Nihon Ciba-Geigy
as well as Novartis Pharma KK due to the merger with Sandoz K.K
As of December 2020

EFPIA Japan
ThinkPark Tower, 2-1-1, Osaki, Shinagawa-ku, Tokyo 141-6017, Japan
Tel: +81-3- 6417-2032
Fax: +81-3- 6685-4870